
X
Switzerland’s Synendos raises CHF 20m for CNS drug development
https://pharmaphorum.com/news/embargo-8am-gmt-12-nov-switzerlands-synendos-raises-chf-20m-for-cns-drug-development/
US non-profit organisation to begin late-stage trials this year
Trial will enrol 5,000 people to determine causes of PTSD.